Price Prediction

Astera Labs (ALAB) Stock Price Prediction: Record Q3 growth collides with a weaker tape and fresh analyst target resets

Astera Labs (ALAB) reported record third-quarter 2026 revenue of $584.9 million on November 3, while the shares were last quoted at $204.16, down 3.12% over 24 hours. Technicals remain pressured be...

Astera Labs (ALAB) Stock Price Prediction: Record Q3 growth collides with a weaker tape and fresh analyst target resets

Record quarter, but the stock is still digesting it

Astera Labs (ALAB) entered the latest trading window with a strong operating update in hand: on November 3, 2026, the company reported record quarterly revenue of $584.9 million, up 49% sequentially and 154% year over year. Management also said Scorpio fabric switches became the company’s largest product family, driven by volume production of the Scorpio X-Series 320-lane fabric switch. That matters because it confirms the growth story is still anchored in execution, not just narrative, and it keeps attention on whether the company can convert product ramp into sustained revenue momentum. citeturn0search0

The market, however, is not treating that print as an open-ended rerating. The latest quoted ALAB price is $204.16, down 3.12% on the day, which leaves the stock well below its 7-day SMA of $215.87, 20-day SMA of $222.01 and 50-day SMA of $278.24. That is a bearish alignment, and it says the post-earnings reaction has not yet translated into trend repair. citeturn0search0

Analyst targets still point higher, but dispersion is wide

On the research side, the tone remains constructive even after a round of target resets. StockAnalysis, citing 25 analysts polled by S&P Global, shows a consensus Buy rating with an average target of $344.15, a low target of $225 and a high of $500. That framework still leaves room for upside from the current quote, but it also shows the street is not unified around one clean valuation path. citeturn0search1

The target changes reported on November 5 add nuance rather than a simple bullish read-through. TradingView said Morgan Stanley raised its target to $389, while UBS, TD Cowen, RBC, Evercore ISI, Susquehanna and Needham cut theirs. In the same coverage, GuruFocus showed the average 12-month target slipping to $365.90 from $414.80, with the range still stretching from $225 to $500. Separately, CNBC reported BMO initiated coverage with an Outperform rating and a $375 target, saying Astera Labs stands to benefit from the AI build-out and describing it as a critical AI networking leader. citeturn0search2turn0search3

The tape is weak, but the derivatives backdrop is firmer

Technically, ALAB is sitting in a mean-reversion zone rather than a confirmed downtrend break. The daily RSI at 38.24 is neutral-to-soft, MACD is negative, and the moving average stack remains bearish with price below all three key averages. The stock is also trading under the Bollinger middle band at $222.01, with the lower band at $169.68 acting as the wider downside boundary. That said, the 24-hour trading range of $211.80 to $199.69 shows the market is still probing for a near-term floor rather than collapsing outright. citeturn0search4

The key levels are straightforward. Immediate support sits at $198.63, with strong support at $193.11. On the upside, the first hurdle is $210.74, followed by strong resistance at $217.33. If the stock can reclaim the pivot near $205.22 and then rebuild above $210.74, the chart starts to look less fragile; if $198.63 gives way, the market is likely to revisit the stronger support band around $193.11. The ATR(14) of $20.97 says volatility is still elevated enough that overshoots around those levels are entirely plausible. citeturn0search4

Binance Futures positioning is more constructive than the spot chart alone suggests. Funding is slightly positive at 0.0094%, open interest jumped 48.67% in 24 hours to 2,522.05 contracts, and taker flow leaned buy-side with a 1-hour taker buy/sell ratio of 1.2019. The global long/short ratio was 1.4802, while top-trader accounts were more tilted long at 2.1928. That does not guarantee direction, but it does show fresh positioning building into the current price band. citeturn0search4

What would change the setup

For ALAB to shift from a corrective tape back into a stronger trend, the stock needs to recover the short-term averages first and then prove it can hold above the $210.74 to $217.33 resistance zone. Without that, the current setup reads as a strong business update trapped inside a technically damaged chart. The next decisive move is likely to come from whether buyers can absorb the post-earnings supply around $198.63 and $193.11, or whether that support finally gives way and forces a deeper mean-reversion move. citeturn0search0turn0search4

Sign in to save this article Free account: build your research collection and return to read it anytime.